Postoperative Analgesia in Hip Arthroplasty
Key facts
- Who runs it
- Balikesir University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 12 Mar 2024
- Ended
- 25 Dec 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- suprainguinal fascia iliaca block
- Pericapsular nerve group (PENG) block
- Record updated
- 16 September 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Volunteer patients undergoing hip arthroplasty
- Voluntary patient to undergo elective operation under regional anaesthesia
- ASA I-II-III
- BMI≤35 kg/m²
Who cannot take part
- Alcohol/Drug addiction
- Used analgesic medication up to 12 hours before surgery
- Local Anaesthetic Allergy
- Psychiatric disorders and medication
- Hematological/Oncological disease
- Severe organ failure
- Infection at the Block Application Site
- Obstacles to the application of regional anaesthesia
- Coagulopathy
- Multiple bone fractures
- Mental Deficiency
- Morbidly obese patients
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to compare the analgesic effectiveness of two blocks in hip arthroplasty. The main question it aims to answer is
Read full original descriptionShow less
-Which block is more efficient? Researchers will compare the suprainguinal fascia iliaca block with the pericapsular nerve group block.
Participants will be randomized, and one of the blocks will be applied.
The 2 groups in the trial
- Suprainguinal fascia iliaca blockExisting treatment, for comparison
The ultrasound-guided suprainguinal fascia iliaca block (SFIB) procedure was first described by Hebbard et al. in 2011. It is a prevalent regional anesthesia technique employed in surgical procedures involving the hip joint and femur. Local anesthetics are administered in close proximity to the fascia iliaca. The primary objective is to obstruct the femoral, obturator and lateral femoral cutaneous nerve in a simultaneous manner. In clinical practice, it is a safe and simple alternative to lumbar plexus blocks and femoral blocks. A 30-ml solution of 0.25% bupivacaine was injected between the iliac muscle and the iliac fascia. The bupivacaine dosage administered in the study was standardized for the groups by employing equal concentrations and volumes.
- Pericapsular nerve group blockExisting treatment, for comparison
In pericapsular nerve group (PENG) block the local anesthetic agent is injected into the musculofascial plane between the psoas muscle tendon and the pubic ramus. The primary objective of this technique is to obstruct the articular branches of the femoral, obturator, and accessory obturator which innervate the hip capsule. Therefore, a comparison with the SFIB was undertaken. A 30-ml block of 0.25% bupivacaine solution was injected between the pubic ramus and the iliopsoas muscle tendon. The bupivacaine dosage administered in the study was standardized for the groups by employing equal concentrations and volumes.
Treatment: Pericapsular nerve group (PENG) block
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of the Postoperative Analgesic Effectiveness of Suprainguinal Fascia Iliaca Block (SFIB) and Pericapsular Nerve Group (PENG) Block in Hip Arthroplasty
- Record updated
- 16 September 2026